Surrozen, Inc./DE (SRZN) stock
SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$29.98−2.34 (-7.24%)
Close on Nov 17, 2026Market cap $352.37MP/E –Yield –
Surrozen price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Surrozen's price to sales ratio was 32.6× on Nov 11, 2026, against 39.4× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 32.6× | −21.2 |
| 2025 | Dec 31, 2025 | 53.7× | – |
See a number that looks wrong?